Salvepar has invested EUR16 million in S2A Group, a multiregional French voluntary sector home care provider, operating in the Pays de la Loire (Aliseo), in the Midi-Pyrénées region (Sadir Assistance) and in Haute Normandie (Adir Assistance).
A number of entities complement the Group in the development of operations in the Ile-de-France (S2A Santé Ile-de-France) or in the area of upcoming technologies focused in particular on telemedicine (H2AD).
The transaction was completed through the acquisition of part of Gemmes Venture’s stake, S2A Group’s majority shareholder, and a subscription to a capital increase of S2A. The capital increase, which was fully supported by the associations which hold shares of S2A, will allow S2A Group to implement its strategic development plan.
As a result of the transaction completed on April 29th, Salvepar holds 14.6% of S2A’s capital and voting rights.
With this investment, Salvepar is willing to:
– support a leading player in home care (oxygen-therapy, ventilation, sleep apnea, drip, nutrition, insulin-therapy…) in its development strategy in a growing and consolidating sector; and
– support the management and the current shareholders toward the development of telemedicine, a market with attractive prospects.
Salvepar will be represented on S2A’s Supervisory Board alongside Gemmes Venture and associations who will keep the chairmanship. With this transaction, Salvepar will bring to S2A Group its expertise in development activities, its vision and access to partners able to support the current strategy including the networks of its shareholders, especially in the insurance and private health insurance sectors.
